The emerging role of carfilzomib combination therapy in the management of multiple myeloma.
about
Oral therapy for multiple myeloma: ixazomib arriving soon.Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2.Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma.Recent advances in defining the ubiquitylome.The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma.Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma.The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target
P2860
Q34047916-9315EB02-E46F-4749-AD7F-13A46A8D12F6Q35592352-9463B93A-03C6-4623-84C0-E8A1D301FD5EQ35969785-6CC898D5-EA3A-4FBC-AB8B-EE4885932932Q37146291-9513DEA1-CC3D-47AC-8CDE-7AC3A08C7A26Q38222939-56468A74-D066-4965-86F1-94D37E1860D5Q38400460-C07158AE-3848-452F-AA95-FD13376CC1A8Q38989789-C33B7FF0-1D97-4121-B003-49869ABA7C3BQ41519882-7952573B-02B8-4E0C-8F97-82BA9D8F3A36
P2860
The emerging role of carfilzomib combination therapy in the management of multiple myeloma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The emerging role of carfilzom ...... anagement of multiple myeloma.
@en
type
label
The emerging role of carfilzom ...... anagement of multiple myeloma.
@en
prefLabel
The emerging role of carfilzom ...... anagement of multiple myeloma.
@en
P2860
P1476
The emerging role of carfilzom ...... anagement of multiple myeloma.
@en
P2093
Philippe Moreau
P2860
P304
P356
10.1586/17474086.2014.873699
P577
2014-02-12T00:00:00Z